Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):497–511. doi: 10.1038/s41575-019-0156-4

Table 1 |.

Genes and proteins affected in polycystic liver diseases

Mutated genes Protein Localization Function
ADPLD (frequency of ~1:100,000)
PRKCSH Hepatocystin or glucosidase II subunit-β ER N-linked glycan-processing enzyme in the ER
SEC63 Translocation protein Sec63 homologue (SEC63) ER Translocation of proteins into the ER lumen
LRP5 Low-density lipoprotein receptor-related protein 5 Plasma membrane Canonical Wnt signalling
GANAB Glucosidase II subunit-α ER N-linked glycan-processing enzyme in the ER
SEC61B Sec61 translocon β-subunit (SEC61β) ER Translocation of proteins into the ER lumen
ALG8 α–1,3-glucosyltransferase ER Protein glycosylation
ADPKD (frequency of ~1:500–1:1,000)
PKD1 Polycystin-1 Primary cilium, plasma membrane and cell junctions Mechanoreceptor involved in calcium signalling
PKD2 Polycystin-2 Primary cilium and ER Non-selective calcium channel
ARPKD, CHF and Caroli disease (frequency of ~1:20,000)
PKHD1 Fibrocystin Primary cilium Tubulogenesis and/or maintenance of bile duct architecture

ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; ARPKD, autosomal recessive polycystic kidney disease; CHF, congenital hepatic fibrosis; ER, endoplasmic reticulum.